Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-27

Clinical Trial Update: A Phase I Study to Evaluate the Safety and PK of ND-340 in Healthy Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the safety and pharmacokinetics of ND-340 in healthy volunteers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ND-340

Snippet

Sponsor: Nang Kuang Pharmaceutical Co., Ltd. | Conditions: Pain, Postoperative | Phase 1 | Status: COMPLETED